Efficient quiescent infection of normal human diploid fibroblasts with wild-type herpes simplex virus type 1

Journal of Virology

Volumn 82, Issue 20, 2008, Pages 10218-10230

  McMahon, Robert ^a   Walsh, Derek ^a  

^a DUBLIN CITY UNIVERSITY   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; ICP0 PROTEIN; ICP22 PROTEIN; ICP4 PROTEIN; IMMEDIATE EARLY PROTEIN; PROMYELOCYTIC LEUKEMIA PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; DIPLOIDY; FIBROBLAST; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN STRUCTURE; VIRUS REPLICATION; WILD TYPE; ANIMAL; CELL CULTURE; CELL NUCLEUS; CULTURE TECHNIQUE; CYTOLOGY; GENETICS; HEAT; METABOLISM; PHYSIOLOGY; ULTRASTRUCTURE; VIROLOGY; VIRUS ACTIVATION;

HUMAN HERPESVIRUS 1; SIMPLEXVIRUS;

ANIMALS; CELL CULTURE TECHNIQUES; CELL NUCLEUS; CELLS, CULTURED; FIBROBLASTS; HEAT; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HUMANS; IMMEDIATE-EARLY PROTEINS; VIRAL PROTEINS; VIRUS ACTIVATION; VIRUS REPLICATION;

EID: 53749092892     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00859-08     Document Type: Article

References (90)

1. Arthur, J. L., C. G. Scarpini, V. Connor, R. H. Lachmann, A. M. Tolkovsky, and S. Efstathiou. 2001. Herpes simplex virus type 1 promoter activity during latency establishment, maintenance, and reactivation in primary dorsal root neurons in vitro. J. Virol. 75:3885-3895.
2. Atanasiu, D., J. R. Kent, J. J. Gartner, and N. W. Fraser. 2006. The stable 2-kb LAT intron of herpes simplex stimulates the expression of heat shock proteins and protects cells from stress. Virology 350:26-33.
3. Blaho, J. A., C. Mitchell, and B. Roizman. 1993. Guanylylation and adenylylation of the alpha regulatory proteins of herpes simplex virus require a viral beta or gamma function. J. Virol. 67:3891-3900.
4. Block, T., S. Barney, J. Masonis, J. Maggioncalda, T. Valyi-Nagy, and N. W. Fraser. 1994. Long term herpes simplex virus type 1 infection of nerve growth factor-treated PC12 cells. J. Gen. Virol. 75:2481-2487.
5. Burkham, J., D. M. Coen, and S. K. Weller. 1998. ND10 protein PML is recruited to herpes simplex virus type 1 prereplicative sites and replication compartments in the presence of viral DNA polymerase. J. Virol. 72:10100-10107.
6. Cai, W., and P. A. Schaffer. 1992. Herpes simplex virus type 1 ICP0 regulates expression of immediate-early, early, and late genes in productively infected cells. J. Virol. 66:2904-2915.
7. Chee, A. V., P. Lopez, P. P. Pandolfi, and B. Roizman. 2003. Promyelocytic leukemia protein mediates interferon-based anti-herpes simplex virus 1 effects. J. Virol. 77:7101-7105.
8. Clements, G. B., and N. D. Stow. 1989. A herpes simplex virus type 1 mutant containing a deletion within immediate early gene 1 is latency-competent in mice. J. Gen. Virol. 70:2501-2506.
9. Colberg-Poley, A. M., H. C. Isom, and F. Rapp. 1979. Reactivation of herpes simplex virus type 2 from a quiescent state by human cytomegalovirus. Proc. Natl. Acad. Sci. USA 76:5948-5951.
10. Crouch, N. A., and F. Rapp. 1972. Cell-dependent differences in the production of infectious herpes simplex virus at a supraoptimal temperature. J. Virol. 9:223-230.
11. Crouch, N. A., and F. Rapp. 1972. Differential effect of temperature on the replication of herpes simplex virus type 1 and type 2. Virology 50:939-941.
12. Danaher, R. J., R. J. Jacob, M. D. Chorak, C. S. Freeman, and C. S. Miller. 1999. Heat stress activates production of herpes simplex virus type 1 from quiescently infected neurally differentiated PC12 cells. J. Neurovirol. 5:374-383.
13. Danaher, R. J., R. J. Jacob, and C. S. Miller. 1999. Establishment of a quiescent herpes simplex virus type 1 infection in neurally differentiated PC12 cells. J. Neurovirol. 5:258-267.
14. Danaher, R. J., R. J. Jacob, and C. S. Miller. 2000. Herpesvirus quiescence in neuronal cells: antiviral conditions not required to establish and maintain HSV-2 quiescence. J. Neurovirol. 6:296-302.
15. Danaher, R. J., R. J. Jacob, and C. S. Miller. 2006. Reactivation from quiescence does not coincide with a global induction of herpes simplex virus type 1 transactivators. Virus Genes 33:163-167.
16. Davido, D. J., W. F. Von Zagorski, G. G. Maul, and P. A. Schaffer. 2003. The differential requirement for cyclin-dependent kinase activities distinguishes two functions of herpes simplex virus type 1 ICP0. J. Virol. 77:12603-12616.
17. Deatly, A. M., J. G. Spivack, E. Lavi, and N. W. Fraser. 1987. RNA from an immediate early region of the type 1 herpes simplex virus genome is present in the trigeminal ganglia of latently infected mice. Proc. Natl. Acad. Sci. USA 84:3204-3208.
18. Everett, R. D., C. Boutell, and A. Orr. 2004. Phenotype of a herpes simplex virus type 1 mutant that fails to express immediate-early regulatory protein ICP0. J. Virol. 78:1763-1774.
19. Everett, R. D., and G. G. Maul. 1994. HSV-1 IE protein Vmw110 causes redistribution of PML. EMBO J. 13:5062-5069.
20. Everett, R. D., and J. Murray. 2005. ND10 components relocate to sites associated with herpes simplex virus type 1 nucleoprotein complexes during virus infection. J. Virol. 79:5078-5089.
21. Everett, R. D., J. Murray, A. Orr, and C. M. Preston. 2007. Herpes simplex virus type 1 genomes are associated with ND10 nuclear substructures in quiescently infected human fibroblasts. J. Virol. 81:10991-11004.
22. Everett, R. D., C. Parada, P. Gripon, H. Sirma, and A. Orr. 2008. Replication of ICP0-null mutant herpes simplex virus type 1 is restricted by both PML and Sp100. J. Virol. 82:2661-2672.
23. Everett, R. D., S. Rechter, P. Papior, N. Tavalai, T. Stamminger, and A. Orr. 2006. PML contributes to a cellular mechanism of repression of herpes simplex virus type 1 infection that is inactivated by ICP0. J. Virol. 80:7995-8005.
24. Feldman, L. T., A. R. Ellison, C. C. Voytek, L. Yang, P. Krause, and T. P. Margolis. 2002. Spontaneous molecular reactivation of herpes simplex virus type 1 latency in mice. Proc. Natl. Acad. Sci. USA 99:978-983.
25. Gilbert, S. C. 2006. Oral shedding of herpes simplex virus type 1 in immunocompetent persons. J. Oral. Pathol. Med. 35:548-553.
26. Halford, W. P., C. D. Kemp, J. A. Isler, D. J. Davido, and P. A. Schaffer. 2001. ICP0, ICP4, or VP16 expressed from adenovirus vectors induces reactivation of latent herpes simplex virus type 1 in primary cultures of latently infected trigeminal ganglion cells. J. Virol. 75:6143-6153.
27. Hammer, S. M., B. S. Richter, and M. S. Hirsch. 1981. Activation and suppression of herpes simplex virus in a human T lymphoid cell line. J. Immunol. 127:144-148.
28. Hancock, M. H., J. A. Corcoran, and J. R. Smiley. 2006. Herpes simplex virus regulatory proteins VP16 and ICP0 counteract an innate intranuclear barrier to viral gene expression. Virology 352:237-252.
29. Harris, R. A., R. D. Everett, X. X. Zhu, S. Silverstein, and C. M. Preston. 1989. Herpes simplex virus type 1 immediate-early protein Vmw110 reactivates latent herpes simplex virus type 2 in an in vitro latency system. J. Virol. 63:3513-3515.
30. Harris, R. A., and C. M. Preston. 1991. Establishment of latency in vitro by the herpes simplex virus type 1 mutant in1814. J. Gen. Virol. 72:907-913.
31. Hobbs, W. E., D. E. Brough, I. Kovesdi, and N. A. DeLuca. 2001. Efficient activation of viral genomes by levels of herpes simplex virus ICP0 insufficient to affect cellular gene expression or cell survival. J. Virol. 75:3391-3403.
32. Hoggan, M. D., and B. Roizman. 1959. The effect of the temperature of incubation on the formation and release of herpes simplex virus in infected FL cells. Virology 8:508-524.
33. Hsu, W. L., and R. D. Everett. 2001. Human neuron-committed teratocarcinoma NT2 cell line has abnormal ND10 structures and is poorly infected by herpes simplex virus type 1. J. Virol. 75:3819-3831.
34. Huang, C. J., M. K. Rice, G. B. Devi-Rao, and E. K. Wagner. 1994. The activity of the pseudorabies virus latency-associated transcript promoter is dependent on its genomic location in herpes simplex virus recombinants as well as on the type of cell infected. J. Virol. 68:1972-1976.
35. Ishov, A. M., and G. G. Maul. 1996. The periphery of nuclear domain 10 (ND10) as site of DNA virus deposition. J. Cell Biol. 134:815-826.
36. Jamieson, D. R., L. H. Robinson, J. I. Daksis, M. J. Nicholl, and C. M. Preston. 1995. Quiescent viral genomes in human fibroblasts after infection with herpes simplex virus type 1 Vmw65 mutants. J. Gen. Virol. 76:1417-1431.
37. Jarman, R. G., E. K. Wagner, and D. C. Bloom. 1999. LAT expression during an acute HSV infection in the mouse. Virology 262:384-397.
38. Johnson, P. A., M. J. Wang, and T. Friedmann. 1994. Improved cell survival by the reduction of immediate-early gene expression in replication-defective mutants of herpes simplex virus type 1 but not by mutation of the virion host shutoff function. J. Virol. 68:6347-6362.
39. Kondo, Y., Y. Yura, H. Iga, T. Yanagawa, H. Yoshida, N. Furumoto, and M. Sato. 1990. Effect of hexamethylene bisacetamide and cyclosporin A on recovery of herpes simplex virus type 2 from the in vitro model of latency in a human neuroblastoma cell line. Cancer Res. 50:7852-7857.
40. Kramer, M. F., and D. M. Coen. 1995. Quantification of transcripts from the ICP4 and thymidine kinase genes in mouse ganglia latently infected with herpes simplex virus. J. Virol. 69:1389-1399.
41. Lancz, G. J., and T. L. Zettlemoyer. 1976. Restricted replication of herpes simplex virus in neural cells. Proc. Soc. Exp. Biol. Med. 152:302-306.
42. Margolis, T. P., F. L. Elfman, D. Leib, N. Pakpour, K. Apakupakul, Y. Imai, and C. Voytek. 2007. Spontaneous reactivation of herpes simplex virus type 1 in latently infected murine sensory ganglia. J. Virol. 81:11069-11074.
43. Marshall, K. R., R. H. Lachmann, S. Efstathiou, A. Rinaldi, and C. M. Preston. 2000. Long-term transgene expression in mice infected with a herpes simplex virus type 1 mutant severely impaired for immediate-early gene expression. J. Virol. 74:956-964.
44. Maul, G. G. 1998. Nuclear domain 10, the site of DNA virus transcription and replication. Bioessays 20:660-667.
45. Maul, G. G., and R. D. Everett. 1994. The nuclear location of PML, a cellular member of the C3HC4 zinc-binding domain protein family, is rearranged during herpes simplex virus infection by the C3HC4 viral protein ICP0. J. Gen. Virol. 75:1223-1233.
46. Miller, C. S., R. J. Danaher, and R. J. Jacob. 2006. ICP0 is not required for efficient stress-induced reactivation of herpes simplex virus type 1 from cultured quiescently infected neuronal cells. J. Virol. 80:3360-3368.
47. Minaker, R. L., K. L. Mossman, and J. R. Smiley. 2005. Functional inaccessibility of quiescent herpes simplex virus genomes. Virol. J. 2:85.
48. Mitchell, C., J. A. Blaho, A. L. McCormick, and B. Roizman. 1997. The nucleotidylylation of herpes simplex virus 1 regulatory protein α22 by human casein kinase II. J. Biol. Chem. 272:25394-25400.
49. Mitchell, C., J. A. Blaho, and B. Roizman. 1994. Casein kinase II specifically nucleotidylylates in vitro the amino acid sequence of the protein encoded by the α22 gene of herpes simplex virus 1. Proc. Natl. Acad. Sci. USA 91:11864-11868.
50. Morrow, J. A., and F. J. Rixon. 1994. Analysis of sequences important for herpes simplex virus type 1 latency-associated transcript promoter activity during lytic infection of tissue culture cells. J. Gen. Virol. 75:309-316.
51. Nichol, P. F., J. Y. Chang, E. M. Johnson, Jr., and P. D. Olivo. 1994. Infection of sympathetic and sensory neurones with herpes simplex virus does not elicit a shut-off of cellular protein synthesis: implications for viral latency and herpes vectors. Neurobiol. Dis. 1:83-94.
52. Nilheden, E., S. Jeansson, and A. Vahlne. 1985. Herpes simplex virus latency in a hyperresistant clone of mouse neuroblastoma (Cl300) cells. Arch. Virol. 83:319-325.
53. Nishiyama, Y., and F. Rapp. 1981. Latency in vitro using irradiated herpes simplex virus. J. Gen. Virol. 52:113-119.
54. Nogueira, M. L., V. E. Wang, D. Tantin, P. A. Sharp, and T. M. Kristie. 2004. Herpes simplex virus infections are arrested in Oct-1-deficient cells. Proc. Natl. Acad. Sci. USA 101:1473-1478.
55. O'Neill, F. J. 1977. Prolongation of herpes simplex virus latency in cultured human cells by temperature elevation. J. Virol. 24:41-46.
56. Preston, C. M. 2007. Reactivation of expression from quiescent herpes simplex virus type 1 genomes in the absence of immediate-early protein ICP0. J. Virol. 81:11781-11789.
57. Preston, C. M., and M. J. Nicholl. 1997. Repression of gene expression upon infection of cells with herpes simplex virus type 1 mutants impaired for immediate-early protein synthesis. J. Virol. 71:7807-7813.
58. Preston, C. M., J. Russell, R. A. Harris, and D. R. Jamieson. 1994. Herpes simplex virus latency in tissue culture cells. Gene Ther. 1(Suppl. 1):S49-S50.
59. Roizman, B., D. M. Knipe, and R. J. Whitley. 2007. Herpes simplex viruses, 5th ed. Lippincott, Williams & Wilkins, Philadelphia, PA.
60. Russell, J., and C. M. Preston. 1986. An in vitro latency system for herpes simplex virus type 2. J. Gen. Virol. 67:397-403.
61. Russell, J., N. D. Stow, E. C. Stow, and C. M. Preston. 1987. Herpes simplex virus genes involved in latency in vitro. J. Gen. Virol. 68:3009-3018.
62. Sacks, W. R., and P. A. Schaffer. 1987. Deletion mutants in the gene encoding the herpes simplex virus type 1 immediate-early protein ICP0 exhibit impaired growth in cell culture. J. Virol. 61:829-839.
63. Samaniego, L. A., L. Neiderhiser, and N. A. DeLuca. 1998. Persistence and expression of the herpes simplex virus genome in the absence of immediate-early proteins. J. Virol. 72:3307-3320.
64. Samaniego, L. A., N. Wu, and N. A. DeLuca. 1997. The herpes simplex virus immediate-early protein ICP0 affects transcription from the viral genome and infected-cell survival in the absence of ICP4 and ICP27. J. Virol. 71:4614-4625.
65. Scheck, A. C., B. Wigdahl, E. De Clercq, and F. Rapp. 1986. Prolonged herpes simplex virus latency in vitro after treatment of infected cells with acyclovir and human leukocyte interferon. Antimicrob. Agents Chemother. 29:589-593.
66. Scheck, A. C., B. Wigdahl, and F. Rapp. 1989. Transcriptional activity of the herpes simplex virus genome during establishment, maintenance, and reactivation of in vitro virus latency. Intervirology 30:121-136.
67. Shiraki, K., and F. Rapp. 1986. Establishment of herpes simplex virus latency in vitro with cycloheximide. J. Gen. Virol. 67:2497-2500.
68. Steiner, I., J. G. Spivack, S. L. Deshmane, C. I. Ace, C. M. Preston, and N. W. Fraser. 1990. A herpes simplex virus type 1 mutant containing a nontransinducing Vmw65 protein establishes latent infection in vivo in the absence of viral replication and reactivates efficiently from explanted trigeminal ganglia. J. Virol. 64:1630-1638.
69. Stow, E. C., and N. D. Stow. 1989. Complementation of a herpes simplex virus type 1 Vmw110 deletion mutant by human cytomegalovirus. J. Gen. Virol. 70:695-704.
70. Stow, N. D., and E. C. Stow. 1986. Isolation and characterization of a herpes simplex virus type 1 mutant containing a deletion within the gene encoding the immediate early polypeptide Vmw110. J. Gen. Virol. 67:2571-2585.
71. Su, Y. H., R. L. Meegalla, R. Chowhan, C. Cubitt, J. E. Oakes, R. N. Lausch, N. W. Fraser, and T. M. Block. 1999. Human corneal cells and other fibroblasts can stimulate the appearance of herpes simplex virus from quiescently infected PC12 cells. J. Virol. 73:4171-4180.
72. Syrjanen, S., H. Mikola, M. Nykanen, and V. Hukkanen. 1996. In vitro establishment of lytic and nonproductive infection by herpes simplex virus type 1 in three-dimensional keratinocyte culture. J. Virol. 70:6524-6528.
73. Vahlne, A., and E. Lycke. 1977. Herpes simplex virus infection of mouse neuroblastoma cells (39880). Proc. Soc. Exp. Biol. Med. 156:82-87.
74. Valyi-Nagy, T., S. L. Deshmane, J. G. Spivack, I. Steiner, C. I. Ace, C. M. Preston, and N. W. Fraser. 1991. Investigation of herpes simplex virus type 1 (HSV-1) gene expression and DNA synthesis during the establishment of latent infection by an HSV-1 mutant, in1814, that does not replicate in mouse trigeminal ganglia. J. Gen. Virol. 72:641-649.
75. Walsh, D., and I. Mohr. 2006. Assembly of an active translation initiation factor complex by a viral protein. Genes Dev. 20:461-472.
76. Walsh, D., and I. Mohr. 2004. Phosphorylation of eIF4E by Mnk-1 enhances HSV-1 translation and replication in quiescent cells. Genes Dev. 18:660-672.
77. Wheeler, C. E. 1958. The effect of temperature upon the production of herpes simplex virus in tissue culture. J. Immunol. 81:98-106.
78. Wigdahl, B., A. C. Scheck, R. J. Ziegler, E. De Clercq, and F. Rapp. 1984. Analysis of the herpes simplex virus genome during in vitro latency in human diploid fibroblasts and rat sensory neurons. J. Virol. 49:205-213.
79. Wigdahl, B., C. A. Smith, H. M. Traglia, and F. Rapp. 1984. Herpes simplex virus latency in isolated human neurons. Proc. Natl. Acad. Sci. USA 81:6217-6221.
80. Wigdahl, B. L., H. C. Isom, E. De Clercq, and F. Rapp. 1982. Activation of herpes simplex virus (HSV) types 1 genome by temperature-sensitive mutants of HSV type 2. Virology 116:468-479.
81. Wigdahl, B. L., H. C. Isom, and F. Rapp. 1981. Repression and activation of the genome of herpes simplex viruses in human cells. Proc. Natl. Acad. Sci. USA 78:6522-6526.
82. Wigdahl, B. L., A. C. Scheck, E. De Clercq, and F. Rapp. 1982. High efficiency latency and activation of herpes simplex virus in human cells. Science 217:1145-1146.
83. Wigdahl, B. L., R. J. Ziegler, M. Sneve, and F. Rapp. 1983. Herpes simplex virus latency and reactivation in isolated rat sensory neurons. Virology 127:159-167.
84. Wilcox, C. L., L. S. Crnic, and L. I. Pizer. 1992. Replication, latent infection, and reactivation in neuronal culture with a herpes simplex virus thymidine kinase-negative mutant. Virology 187:348-352.
85. Wilcox, C. L., and E. M. Johnson, Jr. 1988. Characterization of nerve growth factor-dependent herpes simplex virus latency in neurons in vitro. J. Virol. 62:393-399.
86. Wilcox, C. L., and E. M. Johnson, Jr. 1987. Nerve growth factor deprivation results in the reactivation of latent herpes simplex virus in vitro. J. Virol. 61:2311-2315.
87. Wilcox, C. L., R. L. Smith, C. R. Freed, and E. M. Johnson, Jr. 1990. Nerve growth factor-dependence of herpes simplex virus latency in peripheral sympathetic and sensory neurons in vitro. J. Neurosci. 10:1268-1275.
88. Wysocka, J., and W. Herr. 2003. The herpes simplex virus VP16-induced complex: the makings of a regulatory switch. Trends Biochem. Sci. 28:294-304.
89. Youssoufian, H., S. M. Hammer, M. S. Hirsch, and C. Mulder. 1982. Methylation of the viral genome in an in vitro model of herpes simplex virus latency. Proc. Natl. Acad. Sci. USA 79:2207-2210.
90. Zhu, X. X., J. X. Chen, C. S. Young, and S. Silverstein. 1990. Reactivation of latent herpes simplex virus by adenovirus recombinants encoding mutant IE-0 gene products. J. Virol. 64:4489-4498.